| Product NDC: | 52584-556 |
| Proprietary Name: | Kinevac |
| Non Proprietary Name: | Sincalide |
| Active Ingredient(s): | 5 ug/5mL & nbsp; Sincalide |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-556 |
| Labeler Name: | General Injectables & Vaccines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017697 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101105 |
| Package NDC: | 52584-556-15 |
| Package Description: | 1 VIAL in 1 BAG (52584-556-15) > 5 mL in 1 VIAL |
| NDC Code | 52584-556-15 |
| Proprietary Name | Kinevac |
| Package Description | 1 VIAL in 1 BAG (52584-556-15) > 5 mL in 1 VIAL |
| Product NDC | 52584-556 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sincalide |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101105 |
| Marketing Category Name | NDA |
| Labeler Name | General Injectables & Vaccines, Inc |
| Substance Name | SINCALIDE |
| Strength Number | 5 |
| Strength Unit | ug/5mL |
| Pharmaceutical Classes | Cholecystokinin [Chemical/Ingredient],Cholecystokinin Analog [EPC] |